6533b856fe1ef96bd12b1d35

RESEARCH PRODUCT

Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II.

Thorsten KühnAchim WöckelRicardo FelberbaumRolf KreienbergWolfgang JanniFelix FlockMaria BlettnerSusanne SingerLukas Schwentner

subject

Quality of lifemedicine.medical_specialtyLongitudinal studymedicine.medical_treatmentAngstAnxietyLogistic regressionBreast cancerBreast neoplasms; PsychologyInternal medicinemedicineBrustkrebsBreast neoplasms; Drug therapyddc:610FrauPsychiatryProspective cohort studyLebensqualitätChemotherapybusiness.industryDepressionLebensqualit��tFearKohortenanalysemedicine.diseaseRadiation therapyPatient Health QuestionnaireOncologyAnxietyCohort studiesSurgeryOriginal ArticleWomen; Psychologymedicine.symptombusinessProspective studiesDDC 610 / Medicine & health

description

Background: Fear of cancer treatment can become overwhelming. It is important to understand what patients are mainly afraid of and what factors are correlated with intense fear of treatment. Methods: Patients with primary breast cancer (n = 761) completed questionnaires about fear of treatment before surgery (t1), and before (t2) and after (t3) adjuvant treatment. Psychological co-morbidity was assessed using the Patient Health Questionnaire. Logistic regression identified predictors of intense fear of treatment. Results: Patients were most afraid of chemotherapy (mean score 3.5), and fear remained high throughout follow-up; fear of radiotherapy and of surgery was lower and decreased over time (from 2.7 to 2.2, p < 0.0001; and from 2.6 to 2.2, p < 0.0001, respectively). Patients with psychological co-morbidity (odds ratios (OR) 1.7-3.0) and those who had heard reports of negative experiences with cancer treatments from others (OR 3.8-16.2) were more likely to have intense fear of all the treatments. Patients with a previous cancer less often expressed fear of surgery (OR 0.6, 95% confidence interval 0.4-1.0). Conclusion: Fear of treatment, especially of chemotherapy, is prevalent in many patients with primary breast cancer. Patients with psychological co-morbidity and those who have heard reports of negative experiences with cancer treatment are at higher risk of experiencing intense fear. �� In Copyright http://rightsstatements.org/vocab/InC/1.0/ �� In Copyright http://rightsstatements.org/vocab/InC/1.0/

10.1159/000381933https://pubmed.ncbi.nlm.nih.gov/26195937